Atrial Fibrillation Clinical Trials

A listing of Atrial Fibrillation medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 69 clinical trials
Dual Therapy With Dabigatran/Ticagrelor Versus Dual Therapy With Dabigatran/Clopidogrel in ACS Patients With Indication for NOAC Undergoing PCI

A real world registry to compare dual therapy with Dabigatran/Ticagrelor to dual therapie with Dabigatran/Clopidogrel in patients with an indication for NOAC undergoing PCI in the setting of ACS. Hypothesis: Dual therapy with Dabigatran/Ticagrelor will be non-inferior in reducing the risk of bleeding compared to Dual therapy with Dabigatran/Clopidogrel (RE-DUAL …

  • 0 views
  • 08 May, 2021
  • 1 location
Inhaled Long-acting Bronchodilators With or Without Inhaled Glucocorticosteroids for Preventing Hospitalizations and Death in Elderly Patients With Chronic Obstructive Pulmonary Disease

/or atrial fibrillation) recently hospitalized because of an acute exacerbation of COPD, 12 months treatment with LABD(s)+ICS can increase the time to first re-hospitalization (all cause) and/or death

acute exacerbation of chronic obstructive pulmonary disease
cigarette smoke
heart failure
pulmonary function test
spirometry
  • 5 views
  • 24 Jan, 2021
  • 58 locations
Periprocedural Continuation Versus Interruption of Oral Anticoagulant Drugs During Transcatheter Aortic Valve Implantation (POPular PAUSE TAVI)

4-5% in the first 30 days. Up to 50% of patients undergoing TAVI have an indication for oral anticoagulants (OAC) mostly for atrial fibrillation. OAC use during TAVI could increase bleeding

  • 0 views
  • 27 Jan, 2021
  • 1 location
Beta-blockers to Patients With Chronic Obstructive Pulmonary Disease

. Exclusion criteria include hypersensitivity against metoprolol, atrioventricular (AV) block II or II or sick sinus syndrome without pacemaker, atrial fibrillation or flutter, clinical signs of or previously

copd exacerbation
pulmonary function test
respiratory symptom
asthma
spirometry
  • 21 views
  • 26 Jan, 2021
  • 3 locations
Evaluation of Decreased Usage of Betablockers After Myocardial Infarction in the SWEDEHEART Registry (REDUCE-SWEDEHEART)

Long-term beta-blocker therapy has not been investigated in contemporary randomized clinical trials in patients with myocardial infarction and normal heart function. The aim of this study is to determine whether long-term treatment with oral beta-blockade in patients with myocardial infarction and preserved left ventricular systolic ejection fraction reduces the composite …

stenosis
angiography
beta blocker
beta blockers
coronary artery disease
  • 6 views
  • 25 Jan, 2021
  • 1 location
Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes

Lowering of blood pressure (BP) in high-risk hypertensive individuals reduces major adverse cardiovascular (CV) events. Diabetic patients with hypertension benefit from BP lowering treatment. The present trial, IPAD in brief, is a randomized, open-label, parallel-designed, multicenter study involving nearly 12,000 patients to be recruited over three years and to be …

antidiabetic drug
type 1 diabetes mellitus
hemoglobin a1c
amlodipine 5 mg
hydrochlorothiazide
  • 28 views
  • 25 May, 2021
  • 1 location
Randomized Evaluation of Beta Blocker and ACEI/ARB Treatment in MINOCA Patients - MINOCA-BAT

Myocardial infarction with non-obstructive coronary arteries" (MINOCA) occurs in 5-10% of all patients with AMI. There are neither any randomized clinical trials in MINOCA patients evaluating effects of secondary preventive treatments proven beneficial in patients with classic AMI, nor any treatment guidelines. The primary objective of this multi-national, multi-center pragmatic …

  • 2 views
  • 25 Jan, 2021
  • 18 locations
Targeting Risk Interventions and Metformin for Atrial Fibrillation (TRIM-AF)

The purpose of this study is to perform a prospective, randomized study for the reduction of atrial fibrillation (AF) burden and progression, targeting metabolic upstream therapies. The study

paroxysmal atrial fibrillation
fibrillation
hypertension
antiarrhythmic drug
heart failure
  • 3 views
  • 26 Jan, 2021
  • 1 location
CRyoAblation vs AntiaRrhythmic Drugs for Persistent Atrial Fibrillation Trial

The ablation of pulmonary veins is a very effective treatment for the treatment of paroxysmal atrial fibrillation. The benefit of the isolation of pulmonary veins in persistent atrial

paroxysmal atrial fibrillation
anticoagulants
antiarrhythmic drug
persistent atrial fibrillation
  • 0 views
  • 22 Jan, 2021
Liraglutide Effect in Atrial Fibrillation

Liraglutide will reduce the fat deposits surrounding the participant's heart, and stabilize (and perhaps reduce or eliminate) atrial fibrillation activity.

antiarrhythmic drug
fibrillation
hypertension
catheter ablation
diabetes
  • 17 views
  • 15 May, 2021
  • 1 location